Multidisciplinary/professional organisation
The DCCC ctDNA network protocol will be rooted in relevant DMCG's. The following DMCG's have shown interest in being the anchor for protocols involving ctDNA-based patient stratification: DCCC, DACG, DaBlaCa, DUCG and DaProCa.

Project description
Establishing a national multidisciplinary DCCC circulating tumour DNA network (DCCC ctDNA) to improve the collaboration, research and clinical implementation of ctDNA based biomarkers in the management and treatment of cancer.

The aim of DCCC ctDNA is to stimulate and optimize Danish ctDNA research by facilitating national research studies lead by the DMCG’s. With the network we will create a unique forum, where researchers and clinicians with interest in ctDNA can meet, collaborate and formulate national protocols with the aim of improving cancer treatment in all of Denmark.

Primary contact
Claus Lindbjerg Andersen, PhD, Professor, Department of Molecular Medicine (MOMA), Aarhus University Hospital

Participating parts
Region Zealand:
Niels Pallisgaard, Molecular Biologist, Department of Pathology, Zealand University Hospital, Roskilde Sygehus
Ismail Gogenur, Professor, Department of Surgery, Zealand University Hospital, Køge

Central Denmark Region:
Lars Dyrskjøt, Professor, Department of Molecular Medicine (MOMA), Aarhus University Hospital
Karina Dalsgaard, Professor, Department of Molecular Medicine (MOMA), Aarhus University Hospital
Britt Elmedal Laursen, Consultant, Department of Molecular Medicine (MOMA), Aarhus University Hospital
Claus Lindbjerg Andersen, Professor, Department of Molecular Medicine (MOMA), Aarhus University Hospital
Boe Sandahl Sørensen, Professor, Department of Clinical Biochemistry, Aarhus University Hospital
Karen-Lise Garm Spindler, Chair of DACG, Professor, Consultant, Department of Oncology, Aarhus University Hospital
Lene Hjerrild Iversen, Chair of DCCG, Professor, Consultant, Department of Surgical Gastroenterology, Aarhus University Hospital
Jørgen Bjerggaard Jensen, Chair of DaBlaCa, Professor, Consultant, Department of Urology, Aarhus Universitetshospital
Michael Borre, formand for DMCG.dk, DaProCa, DUCG, professor, overlæge, Urinvejskirurgi, Aarhus University Hospital
Frank Viborg Mortensen, Professor, Department of Surgical Gastroenterology, Aarhus University Hospital
Anders Husted Madsen, Consultant, Department of Surgery, Regional Hospital West Jutland Herning
Kåre G Sunesen, Associate Professor, Speciality Registrar, Department of Surgery, Regional Hospital West Jutland Randers
Uffe Schou Løve, Consultant, Department of Surgery, Regional Hospital West Jutland Viborg
Søren Laurberg, Professor, Department of Clinical Medicine, Aarhus University

The North Denmark Region:
Ole Thorlassius-Ussing, Professor, Department of Surgery, Aalborg University Hospital
Henrik Krarup, Consultant, Department of Clinical Biochemistry, Aalborg University Hospital
Andreas Carus, Consultant, Department of Oncology, Aalborg University Hospital

The Region of Southern Denmark:
Per Vadgaard Andersen, Consultant, Department of Surgery, Odense University Hospital
Henrik Ditzel, Professor, Department of Cancer and Inflammation Research, Department of Molecular Medicine, University of Southern Denmark
Anders Jakobsen, Professor, Department of Oncology, Lillebælt Hospital, Vejle Sygehus
Henrik Jensen, Chair of DSKO, Consultant, Department of Oncology, Lillebælt Hospital, Vejle Sygehus
Rikke Fredslund Andersen, Molecular Biologist, Department of Clinical Biochemistry, Lillebælt Hospital, Vejle Sygehus

The Capital Region of Denmark:
Morten Mau-Sørensen, Consultant, Phase 1 Unit, Department of Oncology, Rigshospitalet
Olga Østrup, Molecular Biologist, Unit of Genomic Medicine, Rigshospitalet
Barbara Malene Fischer, Consultant, Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet
Per Guldberg, Professor, Danish Cancer Society Research Center, Danish Cancer Society
Hans Jørgen Nielsen, Professor, Department of Surgery, Hvidovre Hospital
Helle Pappot, Consultant, Department of Oncology, Rigshospitalet
Gitte Lam, Consultant, Urology Research Unit, Herlev Hospital